Clinical interpretation of prostate-specific antigen values: Type of applied cut-off value exceeds methods bias as the major source of variation.
CONCLUSIONS: This study shows that the differences in cut-off values exceed the method-specific differences. These results emphasize the need for (inter)national harmonization/standardization programmes including cut-off values to allow for laboratory-independent clinical decision-making.
PMID: 30798616 [PubMed - as supplied by publisher]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Klinkenberg LJ, Lentjes EG, Boer AK Tags: Ann Clin Biochem Source Type: research
More News: Cancer | Cancer & Oncology | Laboratory Medicine | Netherlands Health | Prostate Cancer | Study